TRAWS PHARMA INC (TRAW) Stock Balance Sheet
NASDAQ:TRAW - Nasdaq - US68232V8845 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.94M | 21.34M | 20.82M | 38.76M | 55.07M | |||
| Receivables | 1.65M | 1.76M | 18.00K | 29.00K | 28.00K | |||
| Other Current Assets | 1.26M | 1.85M | 1.82M | 561.00K | 332.00K | |||
| Total Current Assets | 18.86M | 24.95M | 22.66M | 39.35M | 55.43M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.00K | 10.00K | 22.00K | 24.00K | 38.00K | |||
| Other Non-Current Assets | 198.00K | 1.00K | 1.00K | 1.00K | 10.00K | |||
| Total Non-Current Assets | 207.00K | 11.00K | 23.00K | 25.00K | 48.00K | |||
| TOTAL ASSETS | 19.06M | 24.96M | 22.68M | 39.37M | 55.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.50M | 2.60M | 3.20M | 3.78M | 2.98M | |||
| Accounts Payable | 7.66M | 8.19M | 5.62M | 3.86M | 2.76M | |||
| Other Current Liabilities | 249.00K | 751.00K | 403.00K | 406.00K | 382.00K | |||
| Total Current Liabilities | 10.40M | 11.53M | 9.22M | 8.05M | 6.12M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.66M | 45.06M | 2.79M | 3.02M | 3.24M | |||
| Total Non-Current Liabilities | 2.66M | 45.06M | 2.79M | 3.02M | 3.24M | |||
| TOTAL LIABILITIES | 13.06M | 56.59M | 12.01M | 11.06M | 9.36M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -627.66M | -649.15M | -482.63M | -463.68M | -444.72M | |||
| Additional Paid In Capital | 633.63M | 617.53M | 493.12M | 491.82M | 490.64M | |||
| Common Shares | 50.00K | 36.00K | 210.00K | 209.00K | 209.00K | |||
| Other Shareholders' Equity | -19.00K | -42.00K | -23.00K | -33.00K | -14.00K | |||
| Shares Outstanding | 5.08M | 3.65M | 840.10K | 837.00K | 835.80K | |||
| Tangible Book Value per Share | 1.18 | -8.66 | 12.70 | 33.82 | 55.18 | |||
| Total Shareholders' Equity | 6.00M | -31.63M | 10.67M | 28.31M | 46.12M | |||
| TOTAL LIABILITIES AND EQUITY | 19.06M | 24.96M | 22.68M | 39.37M | 55.48M | |||
| Statistics | ||||||||
| Current Ratio | 1.81 | 2.16 | 2.46 | 4.89 | 9.06 | |||
| Return On Assets (ROA) | -181.55% | -219.03% | -83.53% | -48.17% | -29.13% | |||
| Return On Equity (ROE) | -576.80% | N/A | -177.55% | -66.99% | -35.05% | |||
All data in USD , ROIC based on taxRate of 0.21